Grail GRAL
NASDAQ GRAL
$80.77 +0.82 (+1.03%)
At close: Sep 18, 2026 · 4:00 PM EDT

Grail (GRAL) Liabilities and Shareholders Equity (2023 - 2026)

Grail's (GRAL) quarterly Liabilities and Shareholders Equity came in at $2.8 billion in Q2 2026, up 5.22% on a YoY basis from $2.7 billion in Q2 2025, and up 1.43% quarter-over-quarter from $2.8 billion in Q1 2026.

Analysis

Grail (GRAL) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

Grail (GRAL) has reported Liabilities and Shareholders Equity for 4 consecutive years, with $2.8 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 5.22% year-over-year to $2.8 billion; the trailing twelve-month figure through Jun 2026 stood at $11.2 billion (down 4.13% YoY), and the FY2025 full-year result was $2.9 billion, down 2.05% from the prior year.
  • Liabilities and Shareholders Equity advanced to $2.8 billion in Q2 2026 per GRAL's latest filing, from $2.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.9 billion in Q4 2023 and bottomed at $2.6 billion in Q3 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $3.0 billion across 4 years, with a median of $2.9 billion in 2025.
  • The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity fell 23.77% in 2024, then grew 5.22% in 2026.
  • Over 4 years, Liabilities and Shareholders Equity stood at $3.9 billion in 2023, then retreated by 23.77% to $3.0 billion in 2024, then fell by 2.05% to $2.9 billion in 2025, then fell by 2.68% to $2.8 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.8 billion, $2.8 billion, and $2.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 2.66 Bn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 16.94 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 18.53 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 1.91 Bn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 2.37 Bn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 1.23 Bn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 3.31 Bn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 729.70 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 640.68 Mn
10 Grail 3.61 Bn 2.75 Bn 21.34 Mn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.84 Bn
Mar 31, 2026 2.80 Bn
Dec 31, 2025 2.92 Bn
Sep 30, 2025 2.60 Bn
Jun 30, 2025 2.70 Bn
Mar 31, 2025 2.85 Bn
Dec 31, 2024 2.98 Bn
Sep 30, 2024 3.12 Bn
Jun 30, 2024 3.27 Bn
Dec 31, 2023 3.91 Bn